Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-17

FDA Approved: METHYLENE BLUE — Original Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved Hikma Pharmaceuticals USA Inc.'s original application for methylene blue, enabling a generic version to be marketed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METHYLENE BLUE (METHYLENE BLUE)

Snippet

ORIG AP for METHYLENE BLUE (METHYLENE BLUE)